Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 30700531)

  • 1. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
    Nguyen LH; Mahadeo T; Bordey A
    J Neurosci; 2019 Apr; 39(14):2762-2773. PubMed ID: 30700531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations.
    Wong M
    Exp Neurol; 2013 Jun; 244():22-6. PubMed ID: 22015915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress.
    Zimmer TS; Korotkov A; Zwakenberg S; Jansen FE; Zwartkruis FJT; Rensing NR; Wong M; Mühlebner A; van Vliet EA; Aronica E; Mills JD
    Brain Pathol; 2021 Sep; 31(5):e12949. PubMed ID: 33786950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis.
    Yasin SA; Ali AM; Tata M; Picker SR; Anderson GW; Latimer-Bowman E; Nicholson SL; Harkness W; Cross JH; Paine SM; Jacques TS
    Acta Neuropathol; 2013 Aug; 126(2):207-18. PubMed ID: 23728790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Sun FJ; Zhang CQ; Chen X; Wei YJ; Li S; Liu SY; Zang ZL; He JJ; Guo W; Yang H
    J Neuroinflammation; 2016 Apr; 13(1):85. PubMed ID: 27095555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
    Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
    Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTOR pathway activation in focal cortical dysplasia.
    Kumari K; Sharma MC; Kakkar A; Malgulwar PB; Pathak P; Suri V; Sarkar C; Chandra SP; Faruq M
    Ann Diagn Pathol; 2020 Jun; 46():151523. PubMed ID: 32325422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell injury and premature neurodegeneration in focal malformations of cortical development.
    Iyer A; Prabowo A; Anink J; Spliet WG; van Rijen PC; Aronica E
    Brain Pathol; 2014 Jan; 24(1):1-17. PubMed ID: 23586324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into a spectrum of developmental malformations related to mTOR dysregulations: challenges and perspectives.
    Mühlebner A; Bongaarts A; Sarnat HB; Scholl T; Aronica E
    J Anat; 2019 Sep; 235(3):521-542. PubMed ID: 30901081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypervascularization in mTOR-dependent focal and global cortical malformations displays differential rapamycin sensitivity.
    Zhang L; Huang T; Teaw S; Bordey A
    Epilepsia; 2019 Jun; 60(6):1255-1265. PubMed ID: 31125447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex.
    Scholl T; Mühlebner A; Ricken G; Gruber V; Fabing A; Samueli S; Gröppel G; Dorfer C; Czech T; Hainfellner JA; Prabowo AS; Reinten RJ; Hoogendijk L; Anink JJ; Aronica E; Feucht M
    Brain Pathol; 2017 Nov; 27(6):770-780. PubMed ID: 27750396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformations.
    Zimmer TS; Ciriminna G; Arena A; Anink JJ; Korotkov A; Jansen FE; van Hecke W; Spliet WG; van Rijen PC; Baayen JC; Idema S; Rensing NR; Wong M; Mills JD; van Vliet EA; Aronica E
    Neuropathol Appl Neurobiol; 2020 Oct; 46(6):546-563. PubMed ID: 31869431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
    Talos DM; Sun H; Kosaras B; Joseph A; Folkerth RD; Poduri A; Madsen JR; Black PM; Jensen FE
    Ann Neurol; 2012 Apr; 71(4):539-51. PubMed ID: 22447678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence.
    Arena A; Zimmer TS; van Scheppingen J; Korotkov A; Anink JJ; Mühlebner A; Jansen FE; van Hecke W; Spliet WG; van Rijen PC; Vezzani A; Baayen JC; Idema S; Iyer AM; Perluigi M; Mills JD; van Vliet EA; Aronica E
    Brain Pathol; 2019 May; 29(3):351-365. PubMed ID: 30303592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H
    Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia.
    Patil VV; Guzman M; Carter AN; Rathore G; Yoshor D; Curry D; Wilfong A; Agadi S; Swann JW; Adesina AM; Bhattacharjee MB; Anderson AE
    Neuropathology; 2016 Apr; 36(2):146-56. PubMed ID: 26381727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal malformations of cortical development: new vistas for molecular pathogenesis.
    Lim KC; Crino PB
    Neuroscience; 2013 Nov; 252():262-76. PubMed ID: 23892008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia.
    Nguyen LH; Brewster AL; Clark ME; Regnier-Golanov A; Sunnen CN; Patil VV; D'Arcangelo G; Anderson AE
    Epilepsia; 2015 Apr; 56(4):636-46. PubMed ID: 25752454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.
    Grajkowska W; Kotulska K; Matyja E; Larysz-Brysz M; Mandera M; Roszkowski M; Domańska-Pakieła D; Lewik-Kowalik J; Jóźwiak S
    Folia Neuropathol; 2008; 46(1):43-8. PubMed ID: 18368626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epilepsy in the mTORopathies: opportunities for precision medicine.
    Moloney PB; Cavalleri GL; Delanty N
    Brain Commun; 2021; 3(4):fcab222. PubMed ID: 34632383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.